CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 3 Insider Initial Statement of Ownership
- 10-Q/A Report 10-Q/A
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Auditor change
- 8-K/A Event Exhibits
- 4/A Grant or award Chief Medical Officer, EVP R&D acquired 30,626 shares (grant or award)
- 4/A Grant or award Chief Executive Officer acquired 153,128 shares (grant or award)
- 4/A Grant or award Chief Financial Officer acquired 24,501 shares (grant or award)
- 8-K Event Executive or director change
- SC 13D/A Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
Page 32 of 62 · 1,224 filings